Titelia

Holdings of E Fund Management Co., Ltd.

444 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 52.7 % of the equity sleeve

Sector breakdown

  • Technology 46.7 %
  • Consumer discretionary 18.5 %
  • Communication 7.7 %
  • Health care 2.5 %
  • Industrials 2.2 %
  • Consumer staples 2.1 %
  • Financials 1.4 %
  • Funds 0.9 %
  • Energy 0.5 %
  • Utilities 0.4 %
  • Materials 0.3 %
  • Real estate 0.1 %
  • Unattributed 16.6 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 76.3 %
  • KY 15.2 %
  • TW 5.5 %
  • NL 1.4 %
  • HK 1.1 %
  • GB 0.3 %
  • CN 0.1 %
  • ZA 0.1 %
  • FR 0.0 %
  • JP 0.0 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US4262.5B $76.26 %
2KY7490.9M $15.24 %
3TW2177.3M $5.50 %
4NL145.3M $1.41 %
5HK135M $1.09 %
6GB18.5M $0.26 %
7CN13.9M $0.12 %
8ZA32.2M $0.07 %
9FR11.5M $0.05 %
10JP1342.5K $0.01 %

Positions

RankCompanySharesValueWeight
401Skyworks Solutions Inc 3,924210.1K $
402AutoZone Inc 62209.4K $
403Digital Realty Trust Inc 1,152207.6K $
404Corvus Pharmaceuticals Inc 14,156207.1K $
405Target Corp 1,679203.5K $
406ONEOK Inc 2,247203.1K $
407EPAM Systems Inc 1,485201.1K $
408Agora Inc 54,555193.1K $
409Iovance Biotherapeutics Inc 54,429191K $
410Relay Therapeutics Inc 18,933188.4K $
411ORIC Pharmaceuticals Inc 14,517183.9K $
412MannKind Corp 73,100179.1K $
413Taysha Gene Therapies Inc 37,699168.5K $
414Geron Corp 111,070165.5K $
415Ford Motor Co 13,975161.3K $
416Precigen Inc 40,126155.3K $
417Vir Biotechnology Inc 16,896151.4K $
418CytomX Therapeutics Inc 30,147141.7K $
419Annexon Inc 25,552141.6K $
420Kura Oncology Inc 16,864137.1K $
421SELLAS Life Sciences Group Inc 31,354132.6K $
422Compass Therapeutics Inc 24,622130.3K $
423Savara Inc 23,752129.7K $
424Sana Biotechnology Inc 44,446128K $
425ARS Pharmaceuticals Inc 14,787118.7K $
426Replimune Group Inc 14,893113.9K $
427Ironwood Pharmaceuticals Inc 27,23095.6K $
428Prime Medicine Inc 27,09994.3K $
429Absci Corp 30,29090.9K $
430Altimmune Inc 29,07289.5K $
431Emergent BioSolutions Inc 10,71088.9K $
432Allogene Therapeutics Inc 35,49286.6K $
433HYPERLIQUID STRATEGIES INC 16,69185K $
434Vanda Pharmaceuticals Inc 11,60380.2K $
435Lexeo Therapeutics Inc 12,68372.8K $
436Verastem Inc 13,71772.7K $
437Myriad Genetics Inc 14,70966.2K $
438Ocugen Inc 35,56264.4K $
439Rocket Pharmaceuticals Inc 17,75163.5K $
440MiMedx Group Inc 15,54361.4K $
441Akebia Therapeutics Inc 41,11957.2K $
442Anavex Life Sciences Corp 18,07055.5K $
443Invivyd Inc 38,50250.1K $
444Perspective Therapeutics Inc 11,66748.7K $